
Chloroplasts (magenta color) in leaves expressing a green fluorescent protein. The DNA encoding for the protein was delivered by targeted nanomaterials without mechanical aid by applying a droplet of the nano-formulation to the leaf surface. (Israel Santana/UCR)
The future of vaccines may look more like eating a salad than getting a shot in the arm. UC Riverside scientists are studying whether they can turn edible plants like lettuce into mRNA vaccine factories.
Messenger RNA or mRNA technology, used in COVID-19 vaccines, works by teaching our cells to recognize and protect us against infectious diseases.
One of the challenges with this new technology is that it must be kept cold to maintain stability during transport and storage. If this new project is successful, plant-based mRNA vaccines — which can be eaten — could overcome this challenge with the ability to be stored at room temperature.
The project’s goals, made possible by a $500,000 grant from the National Science Foundation, are threefold: showing that DNA containing the mRNA vaccines can be successfully delivered into the part of plant cells where it will replicate, demonstrating the plants can produce enough mRNA to rival a traditional shot, and finally, determining the right dosage.
“Ideally, a single plant would produce enough mRNA to vaccinate a single person,” said Juan Pablo Giraldo, an associate professor in UCR’s Department of Botany and Plant Sciences who is leading the research, done in collaboration with scientists from UC San Diego and Carnegie Mellon University.
“We are testing this approach with spinach and lettuce and have long-term goals of people growing it in their own gardens,” Giraldo said. “Farmers could also eventually grow entire fields of it.”
Key to making this work are chloroplasts — small organs in plant cells that convert sunlight into energy the plant can use. “They’re tiny, solar-powered factories that produce sugar and other molecules which allow the plant to grow,” Giraldo said. “They’re also an untapped source for making desirable molecules.”
In the past, Giraldo has shown that it is possible for chloroplasts to express genes that aren’t naturally part of the plant. He and his colleagues did this by sending foreign genetic material into plant cells inside a protective casing. Determining the optimal properties of these casings for delivery into plant cells is a specialty of Giraldo’s laboratory.
For this project Giraldo teamed up with Nicole Steinmetz, a UC San Diego professor of nanoengineering, to utilize nanotechnologies engineered by her team that will deliver genetic material to the chloroplasts.
“Our idea is to repurpose naturally occurring nanoparticles, namely plant viruses, for gene delivery to plants,” Steinmetz said. “Some engineering goes into this to make the nanoparticles go to the chloroplasts and also to render them non-infectious toward the plants.”
For Giraldo, the chance to develop this idea with mRNA is the culmination of a dream. “One of the reasons I started working in nanotechnology was so I could apply it to plants and create new technology solutions. Not just for food, but for high-value products as well, like pharmaceuticals,” Giraldo said.
Giraldo is also co-leading a related project using nanomaterials to deliver nitrogen, a fertilizer, directly to chloroplasts, where plants need it most.
Nitrogen is limited in the environment, but plants need it to grow. Most farmers apply nitrogen to the soil. As a result, roughly half of it ends up in groundwater, contaminating waterways, causing algae blooms, and interacting with other organisms. It also produces nitrous oxide, another pollutant.
This alternative approach would get nitrogen into the chloroplasts through the leaves and control its release, a much more efficient mode of application that could help farmers and improve the environment.
Original Article: Grow and eat your own vaccines?
More from: University of California Riverside | Carnegie Mellon University
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
mRNA factories
- UK house price growth slows to lowest rate since mid-2020; all eyes on Fed decision – business liveon February 1, 2023 at 1:32 am
7-month high The eurozone manufacturing sector downturn continued into the new year, with production volumes and new factory orders falling further ... granted breakthrough therapy designation for its ...
- Analysis of adverse events in older US adults after COVID-19 mRNA vaccinationon January 29, 2023 at 8:54 pm
In a recent study posted to medRxiv*, researchers evaluated adverse events (AEs) in older adults after messenger ribonucleic acid (mRNA) vaccination for coronavirus disease 2019 (COVID-19).
- Bivalent BA.4-5 or BA.1 mRNA-booster given as a fourth dose associated with increased protection against COVID-19 hospitalization and deathon January 29, 2023 at 3:11 pm
4-5 and BA.1 bivalent messenger ribonucleic acid (mRNA)-booster vaccines. Study: Comparative effectiveness of the bivalent BA.4-5 and BA.1 mRNA-booster vaccines in the Nordic countries.
- Egypt inaugurates BioGeneric Pharma factory to produce mRNA vaccines, biologicson January 28, 2023 at 11:57 am
The factory consists for three main units for the ... South Africa and Tunisia will receive vaccine manufacturing support from the WHO’s mRNA technology transfer hub. The African countries ...
- The mRNA synthesis and mRNA manufacturing market is projected to be worth USD 1.5 billion by 2035, claims Roots Analysison January 26, 2023 at 11:06 am
London, Jan. 26, 2023 (GLOBE NEWSWIRE) -- Roots Analysis has announced the addition of "mRNA Synthesis and mRNA Manufacturing Services Market (2nd Edition), 2022–2035" report to its list of ...
Go deeper with Google Headlines on:
mRNA factories
[google_news title=”” keyword=”mRNA factories” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
Plant-based mRNA vaccines
- GreenLight Biosciences receives approval to initiate Phase I/II clinical trial of Covid-19 mRNA vaccine candidateon February 1, 2023 at 6:15 am
The Rwanda FDA has given regulatory approval to GreenLight to start a Phase I/II clinical trial of its Covid-19 vaccine candidate in Rwanda. This phase I/II clinical trial is the first step in ...
- FACTBOX-China mRNA vaccine development jumps into high gearon January 31, 2023 at 9:09 pm
It has declined to use mRNA vaccines from abroad and has yet to approve a domestic one. Below are the major mRNA vaccine candidates being developed in China: WALVAX BIOTECHNOLOGY CO LTD AWcorna, ...
- US FDA grants breakthrough therapy designation for Moderna’s respiratory syncytial virus vaccine candidate, MRNA-1345on January 31, 2023 at 12:30 am
US FDA grants breakthrough therapy designation for Moderna’s respiratory syncytial virus vaccine candidate, MRNA-1345: Cambridge, Massachusetts Tuesday, January 31, 2023, 14:00 ...
- Moderna Granted FDA Breakthrough Therapy Designation for mRNA-1345, An Investigational Respiratory Syncytial Virus (RSV) Vaccine Candidateon January 30, 2023 at 3:14 am
Designation based on positive topline data from the ConquerRSV Phase 3 pivotal efficacy trial, which demonstrated vaccine efficacy of 83.7% against RSV lower respiratory tract disease, defined by 2 or ...
- mRNA vaccine cannot transfer through meat consumptionon January 26, 2023 at 9:52 am
Articles and social media posts claim people can inadvertently receive messenger RNA (mRNA) vaccines by eating meat from inoculated farm animals. This is false; experts say that is not how mRNA ...
Go deeper with Google Headlines on:
Plant-based mRNA vaccines
[google_news title=”” keyword=”plant-based mRNA vaccines” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]